Swiss Rockets and Squirro Team Up to Revolutionize AI in Biotech

Swiss Rockets and Squirro's Groundbreaking Partnership

In a significant move, Swiss Rockets AG, a biotechnology incubator based in Basel, has announced a strategic partnership with Squirro AG, a prominent Swiss enterprise AI company, aiming to accelerate the AI transformation in the biotechnology sector. This collaboration is poised to set a new standard in how biotechnology companies manage information, enhance innovation, and streamline research processes.

The Vision Behind the Partnership

On October 23, 2025, both companies unveiled their plans to utilize Squirro's Generative AI Platform as a critical element of Swiss Rockets' digital infrastructure. This partnership embodies a shared vision to foster innovation and improve decision-making across the biotech portfolio, marking a monumental shift in the way biotechnological research can be conducted.

How AI Will Change the Game

The partnership aims to integrate Squirro's Generative AI and Knowledge Graph technologies within Swiss Rockets' secure environment. This will create a unified intelligence layer that encompasses scientific, operational, and business knowledge. The introduction of an AI-powered assistant will empower Swiss Rockets' teams by providing them with tools to summarize, connect, and clarify vast amounts of information from internal documents, research archives, and publicly available resources.

Sergey Kravchenko, Executive Chairman of Squirro AG, emphasized the potential of AI in today's fast-paced environment, stating, "Artificial intelligence is the best way to do more with fewer resources. With this partnership, Swiss Rockets is demonstrating how responsible AI can drive real business value and innovation in life sciences."

Dr. Vladimir Cmiljanovic, the Founder and CEO of Swiss Rockets AG, added, "Our goal is to make Swiss Rockets a fully AI-empowered organization. Squirro's technology allows us to transform how we manage knowledge, make decisions, and scale innovation – faster, smarter, and more efficiently."

Laying the Groundwork for Future Growth

The agreement outlines an initial rollout of the Swiss Rockets AI Assistant, with plans to explore more AI-driven use cases related to research intelligence, portfolio analytics, and corporate knowledge management. These initiatives will serve as the foundation for Swiss Rockets’ broader AI transformation roadmap, which aims to seamlessly integrate generative AI into everyday operations.

Dr. Dorian Selz, CEO and Co-Founder of Squirro, stated, "This partnership is about building a foundation for continuous learning and growth. Swiss Rockets is setting a strong example of how AI can empower innovation while remaining fully compliant and secure."

Ensuring Security and Compliance

Notably, all systems developed from this collaboration will be hosted in Swiss Rockets' ISO 27001-certified Swiss cloud environment. This assures full compliance with GDPR, HIPAA, and the EU AI Act, addressing the critical issues of data protection and ethical AI deployment. Both organizations are committed to the principles of Responsible AI, placing transparency and data protection at the heart of every new implementation.

About Swiss Rockets AG

Swiss Rockets AG plays a pivotal role within the biotech startup ecosystem, focusing primarily on oncology. By providing essential infrastructure, funding, and operational expertise, it seeks to advance the success of emerging biotech ventures. Founded by a team of experts, including Dr. Vladimir Cmiljanovic and Dr. Natasa Cmiljanovic, Swiss Rockets continues to create pathways for innovation in healthcare.

About Squirro AG

Squirro is recognized as an enterprise-level AI solution tailored for regulated industries. By automating complex workflows and enhancing enterprise search capabilities, Squirro ensures accuracy and compliance in data management, positioning itself as a leader in AI applications.

The synergy between Swiss Rockets and Squirro not only exemplifies the drive towards innovation in biomedicine but also highlights how strategic partnerships can pave the way for future advancements in technology and healthcare.